Cargando…

A novel HCP (heparin-binding protein-C reactive protein-procalcitonin) inflammatory composite model can predict severe acute pancreatitis

Severe acute pancreatitis (SAP) presents with an aggressive clinical presentation and high lethality rate. Early prediction of the severity of acute pancreatitis will help physicians to further precise treatment and improve intervention. This study aims to construct a composite model that can predic...

Descripción completa

Detalles Bibliográficos
Autores principales: Kong, Deshuai, Lei, Zhang, Wang, Zhenyong, Yu, Meng, Li, Jinchao, Chai, Wei, Zhao, Xiulei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256784/
https://www.ncbi.nlm.nih.gov/pubmed/37296194
http://dx.doi.org/10.1038/s41598-023-36552-z
_version_ 1785057180607578112
author Kong, Deshuai
Lei, Zhang
Wang, Zhenyong
Yu, Meng
Li, Jinchao
Chai, Wei
Zhao, Xiulei
author_facet Kong, Deshuai
Lei, Zhang
Wang, Zhenyong
Yu, Meng
Li, Jinchao
Chai, Wei
Zhao, Xiulei
author_sort Kong, Deshuai
collection PubMed
description Severe acute pancreatitis (SAP) presents with an aggressive clinical presentation and high lethality rate. Early prediction of the severity of acute pancreatitis will help physicians to further precise treatment and improve intervention. This study aims to construct a composite model that can predict SAP using inflammatory markers. 212 patients with acute pancreatitis enrolled from January 2018 to June 2020 were included in this study, basic parameters at admission and 24 h after hospitalization, and laboratory results such as inflammatory markers were collected. Pearson's test was used to analyze the correlation between heparin-binding protein (HBP), procalcitonin (PCT), and C-reactive protein (CRP). Risk factors affecting SAP were analyzed using multivariate logistic regression, inflammatory marker models were constructed, and subject operating curves were used to verify the discrimination of individual as well as inflammatory marker models and to find the optimal cut-off value based on the maximum Youden index. In the SAP group, the plasma levels of HBP, CRP, and PCT were 139.1 ± 74.8 ng/mL, 190.7 ± 106.3 mg/L and 46.3 ± 22.3 ng/mL, and 25.3 ± 16.0 ng/mL, 145.4 ± 67.9 mg/L and 27.9 ± 22.4 ng/mL in non-SAP patients, with a statistically significant difference between the two groups (P < 0.001), The Pearson correlation analysis showed a positive correlation between the three values of HBP, CRP, and PCT. The results of the multivariate logistic regression analysis showed that HBP (OR = 1.070 [1.044–1.098], P < 0.001), CRP (OR = 1.010 [1.004–1.016], P = 0.001), and PCT (OR = 1.030[1.007–1.053], P < 0.001) were risk factors for SAP, and the area under the curve of the HBP-CRP-PCT model was 0.963 (0.936–0.990). The HCP model, consisting of HBP, CRP, and PCT; is well differentiated and easy to use and can predict the risk of SAP in advance.
format Online
Article
Text
id pubmed-10256784
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-102567842023-06-11 A novel HCP (heparin-binding protein-C reactive protein-procalcitonin) inflammatory composite model can predict severe acute pancreatitis Kong, Deshuai Lei, Zhang Wang, Zhenyong Yu, Meng Li, Jinchao Chai, Wei Zhao, Xiulei Sci Rep Article Severe acute pancreatitis (SAP) presents with an aggressive clinical presentation and high lethality rate. Early prediction of the severity of acute pancreatitis will help physicians to further precise treatment and improve intervention. This study aims to construct a composite model that can predict SAP using inflammatory markers. 212 patients with acute pancreatitis enrolled from January 2018 to June 2020 were included in this study, basic parameters at admission and 24 h after hospitalization, and laboratory results such as inflammatory markers were collected. Pearson's test was used to analyze the correlation between heparin-binding protein (HBP), procalcitonin (PCT), and C-reactive protein (CRP). Risk factors affecting SAP were analyzed using multivariate logistic regression, inflammatory marker models were constructed, and subject operating curves were used to verify the discrimination of individual as well as inflammatory marker models and to find the optimal cut-off value based on the maximum Youden index. In the SAP group, the plasma levels of HBP, CRP, and PCT were 139.1 ± 74.8 ng/mL, 190.7 ± 106.3 mg/L and 46.3 ± 22.3 ng/mL, and 25.3 ± 16.0 ng/mL, 145.4 ± 67.9 mg/L and 27.9 ± 22.4 ng/mL in non-SAP patients, with a statistically significant difference between the two groups (P < 0.001), The Pearson correlation analysis showed a positive correlation between the three values of HBP, CRP, and PCT. The results of the multivariate logistic regression analysis showed that HBP (OR = 1.070 [1.044–1.098], P < 0.001), CRP (OR = 1.010 [1.004–1.016], P = 0.001), and PCT (OR = 1.030[1.007–1.053], P < 0.001) were risk factors for SAP, and the area under the curve of the HBP-CRP-PCT model was 0.963 (0.936–0.990). The HCP model, consisting of HBP, CRP, and PCT; is well differentiated and easy to use and can predict the risk of SAP in advance. Nature Publishing Group UK 2023-06-09 /pmc/articles/PMC10256784/ /pubmed/37296194 http://dx.doi.org/10.1038/s41598-023-36552-z Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Kong, Deshuai
Lei, Zhang
Wang, Zhenyong
Yu, Meng
Li, Jinchao
Chai, Wei
Zhao, Xiulei
A novel HCP (heparin-binding protein-C reactive protein-procalcitonin) inflammatory composite model can predict severe acute pancreatitis
title A novel HCP (heparin-binding protein-C reactive protein-procalcitonin) inflammatory composite model can predict severe acute pancreatitis
title_full A novel HCP (heparin-binding protein-C reactive protein-procalcitonin) inflammatory composite model can predict severe acute pancreatitis
title_fullStr A novel HCP (heparin-binding protein-C reactive protein-procalcitonin) inflammatory composite model can predict severe acute pancreatitis
title_full_unstemmed A novel HCP (heparin-binding protein-C reactive protein-procalcitonin) inflammatory composite model can predict severe acute pancreatitis
title_short A novel HCP (heparin-binding protein-C reactive protein-procalcitonin) inflammatory composite model can predict severe acute pancreatitis
title_sort novel hcp (heparin-binding protein-c reactive protein-procalcitonin) inflammatory composite model can predict severe acute pancreatitis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256784/
https://www.ncbi.nlm.nih.gov/pubmed/37296194
http://dx.doi.org/10.1038/s41598-023-36552-z
work_keys_str_mv AT kongdeshuai anovelhcpheparinbindingproteincreactiveproteinprocalcitonininflammatorycompositemodelcanpredictsevereacutepancreatitis
AT leizhang anovelhcpheparinbindingproteincreactiveproteinprocalcitonininflammatorycompositemodelcanpredictsevereacutepancreatitis
AT wangzhenyong anovelhcpheparinbindingproteincreactiveproteinprocalcitonininflammatorycompositemodelcanpredictsevereacutepancreatitis
AT yumeng anovelhcpheparinbindingproteincreactiveproteinprocalcitonininflammatorycompositemodelcanpredictsevereacutepancreatitis
AT lijinchao anovelhcpheparinbindingproteincreactiveproteinprocalcitonininflammatorycompositemodelcanpredictsevereacutepancreatitis
AT chaiwei anovelhcpheparinbindingproteincreactiveproteinprocalcitonininflammatorycompositemodelcanpredictsevereacutepancreatitis
AT zhaoxiulei anovelhcpheparinbindingproteincreactiveproteinprocalcitonininflammatorycompositemodelcanpredictsevereacutepancreatitis
AT kongdeshuai novelhcpheparinbindingproteincreactiveproteinprocalcitonininflammatorycompositemodelcanpredictsevereacutepancreatitis
AT leizhang novelhcpheparinbindingproteincreactiveproteinprocalcitonininflammatorycompositemodelcanpredictsevereacutepancreatitis
AT wangzhenyong novelhcpheparinbindingproteincreactiveproteinprocalcitonininflammatorycompositemodelcanpredictsevereacutepancreatitis
AT yumeng novelhcpheparinbindingproteincreactiveproteinprocalcitonininflammatorycompositemodelcanpredictsevereacutepancreatitis
AT lijinchao novelhcpheparinbindingproteincreactiveproteinprocalcitonininflammatorycompositemodelcanpredictsevereacutepancreatitis
AT chaiwei novelhcpheparinbindingproteincreactiveproteinprocalcitonininflammatorycompositemodelcanpredictsevereacutepancreatitis
AT zhaoxiulei novelhcpheparinbindingproteincreactiveproteinprocalcitonininflammatorycompositemodelcanpredictsevereacutepancreatitis